trending Market Intelligence /marketintelligence/en/news-insights/trending/f-QlX6Ynyb3qDlOBj4Jyyg2 content esgSubNav
In This List

Wright Medical acquires software developer IMASCAP

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Wright Medical acquires software developer IMASCAP

Wright Medical Group NV acquired 100% of IMASCAP SAS' outstanding equity for total consideration of €75.1 million.

IMASCAP develops software for preoperative planning of shoulder replacement surgery.

The consideration consists of about €39.7 million in cash; about €13.2 million of Wright ordinary shares, payable at closing; and €22.2 million in potential earnouts and milestone payments for new software modules and a potential future implant system.

Due to the timing of the closing, Wright Medical expects incurring minimal incremental expenses in 2017 and is maintaining its current full-year 2017 non-GAAP adjusted EBITDA from continuing operations guidance range of $84 million to $88 million.